Bloomberg reports the Kennedy plan to widen peptide access comes with a side effect reporting rule for compounding pharmacies.
Recap by typeshit. Full story at Bloomberg.com.
A Facebook user explains that compounded GLP-1 versions were allowed during the branded drug shortage and flags what that means for people still using them.
Sahpra reports about 600 fake medicine complaints this year, and new compounding rules aren't due until early next year, which industry head Stavros Nicolaou calls too late.
The Warrington Guardian reports charges against staff over the theft of weight-loss injections valued at around £20,000.
Asahi Shimbun reports the arrests tied to prescription-free sales of Mounjaro and similar weight loss drugs riding the diet craze.
The Illinois governor is open about his GLP-1 use, a Facebook post notes, framing it as a response to jabs from the current president.
The 45-year-old comedian posted a wetsuit photo thanking the drug. She has lost 50 pounds on it since going public in March 2025.
Loading…